Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Fasting alters the gut microbiome reducing blood pressure and body weight in metabolic syndrome patients

[img]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
3MB
[img] Other (Supplementary Material)
11MB

Item Type:Article
Title:Fasting alters the gut microbiome reducing blood pressure and body weight in metabolic syndrome patients
Creators Name:Maifeld, A. and Bartolomaeus, H. and Löber, U. and Avery, E.G. and Steckhan, N. and Markó, L. and Wilck, N. and Hamad, I. and Šušnjar, U. and Mähler, A. and Hohmann, C. and Chen, C.Y. and Cramer, H. and Dobos, G. and Lesker, T.R. and Strowig, T. and Dechend, R. and Bzdok, D. and Kleinewietfeld, M. and Michalsen, A. and Müller, D.N. and Forslund, S.K.
Abstract:Periods of fasting and refeeding may reduce cardiometabolic risk elevated by Western diet. Here we show in the substudy of NCT02099968, investigating the clinical parameters, the immunome and gut microbiome exploratory endpoints, that in hypertensive metabolic syndrome patients, a 5-day fast followed by a modified Dietary Approach to Stop Hypertension diet reduces systolic blood pressure, need for antihypertensive medications, body-mass index at three months post intervention compared to a modified Dietary Approach to Stop Hypertension diet alone. Fasting alters the gut microbiome, impacting bacterial taxa and gene modules associated with short-chain fatty acid production. Cross-system analyses reveal a positive correlation of circulating mucosa-associated invariant T cells, non-classical monocytes and CD4(+) effector T cells with systolic blood pressure. Furthermore, regulatory T cells positively correlate with body-mass index and weight. Machine learning analysis of baseline immunome or microbiome data predicts sustained systolic blood pressure response within the fasting group, identifying CD8(+) effector T cells, Th17 cells and regulatory T cells or Desulfovibrionaceae, Hydrogenoanaerobacterium, Akkermansia, and Ruminococcaceae as important contributors to the model. Here we report that the high-resolution multi-omics data highlight fasting as a promising non-pharmacological intervention for the treatment of high blood pressure in metabolic syndrome patients.
Keywords:Akkermansia, Blood Pressure, Body Mass Index, Body Weight, Desulfovibrionaceae, Diet, Fasting, Feces, Gastrointestinal Microbiome, Hypertension, Metabolic Syndrome, Ruminococcus, T-Lymphocyte Subsets
Source:Nature Communications
ISSN:2041-1723
Publisher:Nature Publishing Group
Volume:12
Number:1
Page Range:1970
Date:30 March 2021
Official Publication:https://doi.org/10.1038/s41467-021-22097-0
PubMed:View item in PubMed
Related to:
URLURL Type
https://edoc.mdc-berlin.de/20055/Preprint version

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library